The stock price of Creative Medical Technology Holdings Inc (NASDAQ: CELZ) has dropped by -8.99 compared to previous close of 4.56. Despite this, the company has seen a fall of -16.50% in its stock price over the last five trading days. globenewswire.com reported 2025-03-06 that PHOENIX, March 06, 2025 (GLOBE NEWSWIRE) — Creative Medical Technology Holdings, Inc., (Nasdaq: CELZ) (the “Company”), a leading biotechnology innovator in regenerative medicine, today announced it has entered into agreements with certain holders of its existing warrants for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 837,104 shares of common stock of the Company originally issued in October 2024 at their current exercise price of $4.42 per share. The shares of common stock issuable upon exercise of the existing warrants are registered pursuant to an effective registration statement on Form S-1 (File No. 333-283091). The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $3.7 million, before deducting financial advisory fees.
Is It Worth Investing in Creative Medical Technology Holdings Inc (NASDAQ: CELZ) Right Now?
The 36-month beta value for CELZ is at 4.42. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CELZ is 1.71M, and currently, shorts hold a 5.75% of that float. The average trading volume for CELZ on March 10, 2025 was 81.42K shares.
CELZ’s Market Performance
CELZ stock saw an increase of -16.50% in the past week, with a monthly gain of 15.60% and a quarterly increase of 69.39%. The volatility ratio for the week is 24.86%, and the volatility levels for the last 30 days are 19.42% for Creative Medical Technology Holdings Inc (CELZ). The simple moving average for the past 20 days is -15.99% for CELZ’s stock, with a 20.55% simple moving average for the past 200 days.
CELZ Trading at 17.37% from the 50-Day Moving Average
After a stumble in the market that brought CELZ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -59.64% of loss for the given period.
Volatility was left at 19.42%, however, over the last 30 days, the volatility rate increased by 24.86%, as shares surge +16.90% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +100.48% upper at present.
During the last 5 trading sessions, CELZ fell by -16.50%, which changed the moving average for the period of 200-days by -6.74% in comparison to the 20-day moving average, which settled at $4.94. In addition, Creative Medical Technology Holdings Inc saw 79.65% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CELZ starting from Finger Michael H., who sale 750 shares at the price of $5.75 back on Feb 19 ’25. After this action, Finger Michael H. now owns 351 shares of Creative Medical Technology Holdings Inc, valued at $4,312 using the latest closing price.
Finger Michael H., the Director of Creative Medical Technology Holdings Inc, sale 750 shares at $5.00 during a trade that took place back on Feb 18 ’25, which means that Finger Michael H. is holding 1,101 shares at $3,750 based on the most recent closing price.
Stock Fundamentals for CELZ
Current profitability levels for the company are sitting at:
- -511.82 for the present operating margin
- -7.04 for the gross margin
The net margin for Creative Medical Technology Holdings Inc stands at -483.45. The total capital return value is set at -0.86. Equity return is now at value -57.03, with -54.82 for asset returns.
Currently, EBITDA for the company is -5.53 million with net debt to EBITDA at 1.15. When we switch over and look at the enterprise to sales, we see a ratio of 90.28. The liquidity ratio also appears to be rather interesting for investors as it stands at 19.13.
Conclusion
In conclusion, Creative Medical Technology Holdings Inc (CELZ) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
